# Jiangsu Huili Biological Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-huili-biological-technology-co

- Industry: Biotechnology
- Headquarters: Taizhou, China
- Website: www.huilibio.com
- Total disclosed funding: $45M
- Latest round: Series A (Jul 4, 2022)
- Investors on record: 6

## About

Established in 2003 and based in Taizhou, China, Jiangsu Huili Biological Technology Co., Ltd is a biotechnology company that focuses on the computational design of enzyme components at the heart of synthetic biological reactions. Hongming Guo will remain as CEO of Jiangsu Huili Biological Technology Co., Ltd. The company has completed 2 rounds of funding as of 2022. The company is headquartered in Taizhou, with an R&D center in Tianjin and a production base in Taizhou.

The company's main business is research and technology transfer of biological engineering technology, research and development, production and marketing of high-tech products such as pharmaceutical intermediates, pharmaceutical health products and nutritional products and enzyme preparations. The company's self-developed products include pharmaceutical intermediates such as D-p-methylsulfonyl phenylserine ethyl ester, D-Proline and (S)-BOC-piperidinol, functional food ingredients such as D-Proline, Selenium-enriched yeast and Hydroxytyrosol, enzyme products and other products.

The company plans to use the funding to accelerate the construction and operation of large-scale production facilities, the research and development of the core enzyme pipeline for synthetic biological reactions, and the expansion of the human resources team.

## Funding rounds

- Series A, Jul 4, 2022, $45M — Legend Capital, Cenova Ventures, Yunqi Partners, ZWC Ventures, BioTrack Capital
- Angel, Feb 3, 2021 — Addor Capital

## Investors

- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Angel
- Legend Capital — Series A
- Cenova Ventures (https://capitalatlas.ai/funds/cenova-ventures) — Series A
- Yunqi Partners (https://capitalatlas.ai/funds/yunqi-partners) — Series A
- ZWC Ventures (https://capitalatlas.ai/funds/zwc-ventures) — Series A
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series A